Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: A report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS collaborating group

Journal of Clinical Oncology

Volumn 25, Issue 25, 2007, Pages 3831-3836

  Brohet, Richard M ^b   Goldgar, David E ^b   Easton, Douglas F ^b   Antoniou, Antonis C ^b   Andrieu, Nadine ^b   Chang Claude, Jenny ^b   Peock, Susan ^b   Eeles, Rosalind A ^b   Cook, Margaret ^b   Chu, Carol ^b   Noguès, Catherine ^b   Lasset, Christine ^b   Berthet, Pascaline ^b   Meijers Heijboer, Hanne ^b   Gerdes, Anne Marie ^b   Olsson, Håkan ^b   Caldes, Trinidad ^b   Van Leeuwen, Flora E ^b   Rookus, Matti A ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PREGNANCY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34548538897     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.1179     Document Type: Article

References (20)

1. Ford D, Easton DF, Stratton M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676-689, 1998
2. Antoniou A, Pharoah PD, Narod S, et al: Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet 72:1117-1130, 2003
3. Rebbeck TR, Lynch HT, Neuhausen SL, et al: Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616-1622, 2002
4. Kauff ND, Satagopan JM, Robson ME, et al: Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609-1615, 2002
5. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies: Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 347:1713-1727, 1996
6. Narod SA, Risch H, Moslehi R, et al: Oral contraceptives and the risk of hereditary ovarian cancer: Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med 339:424-428, 1998
7. McGuire V, Felberg A, Mills M, et al: Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations. Am J Epidemiol 160:613-618, 2004
8. Whittemore AS, Balise RR, Pharoah PD, et al: Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. Br J Cancer 91:1911-1915, 2004
9. McLaughlin JR, Risch HA, Lubinski J, et al: Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: A case-control study. Lancet Oncol 8:26-34, 2007
10. Modan B, Hartge P, Hirsh-Yechezkel G, et al: Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med 345:235-240, 2001
11. Ursin G, Henderson BE, Haile RW, et al: Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Res 57:3678-3681, 1997
12. Jernström H, Loman N, Johannsson OT, et al: Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing. Eur J Cancer 41:2312-2320, 2005
13. Narod SA, Dube MP, Klijn J, et al: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 94:1773-1779, 2002
14. Heimdal K, Skovlund E, Moller P: Oral contraceptives and risk of familial breast cancer. Cancer Detect Prev 26:23-27, 2002
15. Milne RL, Knight JA, John EM, et al: Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 14:350-356, 2005
16. Haile RW, Thomas DC, McGuire V, et al: BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev 15:1863-1870, 2006
17. Goldgar D, Bonnardel C, Renard H, et al: The International BRCA1/2 Carrier Cohort Study: Purpose, rationale, and study design. http://breast- cancer-research.com/content/2/6/E010
18. Andrieu N, Easton DF, Chang-Claude J, et al: Effect of chest x-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the International BRCA1/2 Carrier Cohort Study. J Clin Oncol 24:3361-3366, 2006
19. Andrieu N, Goldgar DE, Easton DF, et al: Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 98:535-544, 2006
20. Antoniou AC, Goldgar DE, Andrieu N, et al: A weighted cohort approach for analyzing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 29:1-11, 2005 0